Natasha Leighl, MD, MMSC, FRCPC, FASCO
Department of Medicine
University of Toronto
Lung Site Lead
Department of Medical Oncology and Hematology
Princess Margaret Cancer Centre
Toronto, Ontario, Canada
Natasha Leighl, MD, MMsc, FRCPC, FASCO, has disclosed that she has received funds for research support from Amgen, Array, AstraZeneca, Bayer, Bristol Myers Squibb, Eli Lilly, EMD Serono, Guardant Health, Inivata, MSD, Novartis, Pfizer, Roche, and Takeda and consultant/advisor/ speaker fees for Amgen, Bristol Myers Squibb, GlaxoSmithKline, MSD, Novartis, Puma Biotechnology, Sanofi Genzyme, and Takeda.